Identity
- Security key
- 13607
- Ticker
- CODX
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2017-07-12
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- CODX
Detail
Enriched 2026-08-14 20:47
- Market cap
- $5,454,264.72
- Shares outstanding (class)
- 5,278,957
- Shares outstanding (weighted)
- 3,685,314
- SIC
- 3841 SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
- Employees
- 115
- Location
- SALT LAKE CITY, UT
- Homepage
- https://www.codiagnostics.com
- Description
Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
Market cap and share counts drift.